Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
DOI:
https://doi.org/10.2340/sju.v58.14730Keywords:
Prostate cancer, treatment, shared decision making, wish, experienceAbstract
Objective: In comparable men with non-metastatic prostate cancer, radical prostatectomy (RP), radiotherapy (RAD) and active surveillance (AS) are treatment options with similar survival rates, but different side-effects. Healthcare professionals consider pretreatment shared decision making (SDM) to be an essential part of medical care, though the patients’ view about SDM is less known. In this article, we explore prostate cancer (PCa) patients’ SDM wish (SDMwish), and experiences (SDMexp).
Material and methods: This is a registry-based survey performed by the Cancer Registry of Norway (2017–2019). One year after diagnosis, 5,063 curatively treated PCa patients responded to questions about their pre-treatment wish and experience regarding SDM. Multivariable analyses identified factors associated with SDM. Statistical significance level: p < 0.05.
Results: Overall, 78% of the patients wished to be involved in SDM and 83% of these had experienced SDM. SDMwish and SDMexp was significantly associated with decreasing age, increasing education, and living with a partner. Compared with the RP group, the probability of SDMwish and SDMexp was reduced by about 40% in the RAD and the AS groups.
Conclusion: Three of four curatively treated PCa wanted to participate in SDM, and this wish was met in four of five men. Younger PCa patients with higher education in a relationship, and opting for RP, wanted an active role in SDM, and experienced being involved. Effective SDM requires the responsible physicians’ attention to the individual patients’ characteristics and needs.
Downloads
References
Cancer Registry of Norway. Cancer in Norway 2021 – cancer incidence, mortality, survival and prevalence in Norway. 2022.[cited 2023 Feb 14]. Available from: https://www.kreftregisteret.no/globalassets/cancer-in-norway/2021/cin_report.pdf
Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243–62. https://doi.org/10.1016/j.eururo.2020.09.042 DOI: https://doi.org/10.1016/j.eururo.2020.09.042
Hamdy FC, Donovan JL, Lane JA, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2023;388(17):1547-1558.https://doi.org/10.1056/NEJMoa2214122 DOI: https://doi.org/10.1016/j.eururo.2023.08.014
Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes 12 years after localized prostate cancer treatment. NEJM Evid. 2023;2(4). https://doi.org/10.1056/EVIDx2300122 DOI: https://doi.org/10.1056/EVIDx2300122
Wollersheim BM, van Stam MA, Bosch RJLH, et al. Unmet expectations in prostate cancer patients and their association with decision regret. J Cancer Surviv. 2020;14(5):731–8. https://doi.org/10.1007/s11764-020-00888-6 DOI: https://doi.org/10.1007/s11764-020-00888-6
Meissner VH, Simson BW, Dinkel A, et al. Treatment decision regret in long-term survivors after radical prostatectomy: a longitudinal study. BJU Int. 2022;131(5):623-630. https://doi.org/10.1111/bju.15955 DOI: https://doi.org/10.1111/bju.15955
Lechner S, Herzog W, Boehlen F, et al. Control preferences in treatment decisions among older adults – results of a large population-based study. J Psychosom Res. 2016;86:28–33. https://doi.org/10.1016/j.jpsychores.2016.05.004 DOI: https://doi.org/10.1016/j.jpsychores.2016.05.004
Spooner K, Chima C, Salemi JL, Zoorob RJ, Self-reported preferences for patient and provider roles in cancer treatment decision-making in the United State. Fam Med Commun Health. 2017;5(1):43–55. https://doi.org/10.15212/FMCH.2017.0102 DOI: https://doi.org/10.15212/FMCH.2017.0102
Ihrig A, Maatouk I, Friederich HC, et al. The treatment decision-making preferences of patients with prostate cancer should be recorded in research and clinical routine: a pooled analysis of four survey studies with 7169 patients. J Cancer Educ. 2022;37(3):675–82. https://doi.org/10.1007/s13187-020-01867-2 DOI: https://doi.org/10.1007/s13187-020-01867-2
Drummond FJ, Gavin AT, Sharp L. Incongruence in treatment decision making is associated with lower health-related quality of life among prostate cancer survivors: results from the PiCTure study. Support Care Cancer. 2018;26(5):1645–54. https://doi.org/10.1007/s00520-017-3994-z DOI: https://doi.org/10.1007/s00520-017-3994-z
Yennurajalingam S, Rodrigues LF, Shamieh OM, et al. Decisional control preferences among patients with advanced cancer: an international multicenter cross-sectional survey. Palliat Med. 2018;32(4):870–80. https://doi.org/10.1177/0269216317747442 DOI: https://doi.org/10.1177/0269216317747442
Schaede U, Mahlich J, Nakayama M, et al Shared decision-making in patients with prostate cancer in Japan: patient preferences versus physician perceptions. J Glob Oncol. 2018;4:1–9. https://doi.org/10.1200/JGO.2016.008045 DOI: https://doi.org/10.1200/JGO.2016.008045
Davison BJ, Degner LF, Morgan TR. Information and decision-making preferences of men with prostate cancer. Oncol Nurs Forum. 1995;22(9):1401–8.
Davison BJ, Gleave ME, Goldenberg SL, et al. Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nurs. 2002;25(1):42–9. https://doi.org/10.1097/00002820-200202000-00009 DOI: https://doi.org/10.1097/00002820-200202000-00009
Davison BJ, Parker PA, Goldenberg SL. Patients’ preferences for communicating a prostate cancer diagnosis and participating in medical decision-making. BJU Int. 2004;93(1):47–51. https://doi.org/10.1111/j.1464-410X.2004.04553.x DOI: https://doi.org/10.1111/j.1464-410X.2004.04553.x
Hurwitz LM, Cullen J, Elsamanoudi S, et al. A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic. Urol Oncol. 2016;34(5):233.e17–25. https://doi.org/10.1016/j.urolonc.2015.11.014 DOI: https://doi.org/10.1016/j.urolonc.2015.11.014
Orom H, Biddle C, Underwood W, et al. What is a “Good” treatment decision? Decisional control, knowledge, treatment decision making, and quality of life in men with clinically localized prostate cancer. Med Decis Making. 2016;36(6):714–25. https://doi.org/10.1177/0272989X16635633 DOI: https://doi.org/10.1177/0272989X16635633
van Stam MA, Pieterse AH, van der Poel HG, et al. Shared decision making in prostate cancer care-encouraging every patient to be actively involved in decision making or ensuring the patient preferred level of involvement? J Urol. 2018;200(3):582–9. https://doi.org/10.1016/j.juro.2018.02.3091 DOI: https://doi.org/10.1016/j.juro.2018.02.3091
Hernes E, Kyrdalen A, Kvåle R, et al. Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry. BJU Int. 2010;105(6):805–11; discussion 811. https://doi.org/10.1111/j.1464-410X.2009.08834.x DOI: https://doi.org/10.1111/j.1464-410X.2009.08834.x
Sørensen JB, Klee M, Palshof T, et al. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer. 1993;67(4):773–5. https://doi.org/10.1038/bjc.1993.140 DOI: https://doi.org/10.1038/bjc.1993.140
Folkehelseinstituttet. Spørreskjemabanken; 2014. [cited 2022 Nov 15]. Available from: https://www.fhi.no/kk/brukererfaringer/sporreskjemabanken2/
Bjertnaes OA, Sjetne IS, Iversen HH. Overall patient satisfaction with hospitals: effects of patient-reported experiences and fulfilment of expectations. BMJ Qual Saf. 2012;21(1):39–46. https://doi.org/10.1136/bmjqs-2011-000137 DOI: https://doi.org/10.1136/bmjqs-2011-000137
Iversen HH, Holmboe O, Bjertnæs OA. The cancer patient experiences questionnaire. (CPEQ): reliability and construct validity following a national survey to assess hospital cancer care from the patient perspective. BMJ Open. 2012;2:e001437. https://doi.org/10.1136/bmjopen-2012-001437 DOI: https://doi.org/10.1136/bmjopen-2012-001437
Hubbard G, Kidd L, Donaghy E. Preferences for involvement in treatment decision making of patients with cancer: a review of the literature. Eur J Oncol Nurs. 2008;12(4):299–318. https://doi.org/10.1016/j.ejon.2008.03.004 DOI: https://doi.org/10.1016/j.ejon.2008.03.004
Brom, L, Hopmans W, Pasman HR, et al. Congruence between patients’ preferred and perceived participation in medical decision-making: a review of the literature. BMC Med Inform Decis Mak. 2014;14:25. https://doi.org/10.1186/1472-6947-14-25 DOI: https://doi.org/10.1186/1472-6947-14-25
Cuypers M, Lamers RED, de Vries M, et al. Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: results from the PROFILES registry. Urol Oncol. 2016;34(11):482.e11–18. https://doi.org/10.1016/j.urolonc.2016.06.015 DOI: https://doi.org/10.1016/j.urolonc.2016.06.015
van Stam MA, van der Poel HG, van der Voort van Zyp JRN, et al. The accuracy of patients’ perceptions of the risks associated with localised prostate cancer treatments. BJU Int. 2018;121(3):405–14. https://doi.org/10.1111/bju.14034 DOI: https://doi.org/10.1111/bju.14034
Donovan JL. Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring. J Natl Cancer Inst Monogr. 2012;2012(45):191–6. https://doi.org/10.1093/jncimonographs/lgs030 DOI: https://doi.org/10.1093/jncimonographs/lgs030
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mona Otrebski Nilsson, Kirsti Aas, Tor Å. Myklebust, Ylva Maria Gjelsvik, Erik Skaaheim Haug, Sophie D. Fosså, Tom Børge Johannesen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
